Back to Search
GORDON PETERS, MD
MD
Aerospace Medicine Physician
NPI: 1538141320Individual
Specialties, Licenses & Credentials
Aerospace Medicine PhysicianPrimary
Preventive Medicine — Aerospace Medicine
Code: 2083A0100X
35060760P(OH)
Research & Publications (20)
Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer.
PMID 19632929·Clin Colorectal Cancer·2009
4-observational
A structured review of reasons for ecstasy use and related behaviours: pointers for future research.
PMID 19594926·BMC Public Health·2009
6-review
Cell cycle effects and increased adduct formation by temozolomide enhance the effect of cytotoxic and targeted agents in lung cancer cell lines.
PMID 19567356·J Chemother·2009
7-preclinical
A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion.
PMID 19556122·Eur J Cancer·2009
3-trial
The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation.
PMID 19541653·Proc Natl Acad Sci U S A·2009
7-preclinical
Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines.
PMID 19531575·Mol Cancer Ther·2009
8-other
Environmental comparison of biosolids management systems using life cycle assessment.
PMID 19475933·Environ Sci Technol·2009
4-observational
Expression of Pls (plasmin sensitive) in Staphylococcus aureus negative for pls reduces adherence and cellular invasion and acts by steric hindrance.
PMID 19473097·J Infect Dis·2009
8-other
Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS.
PMID 19451218·Genes Dev·2009
7-preclinical
RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress.
PMID 19448675·Oncogene·2009
8-other
Phenotypic expansion and further characterisation of the 17q21.31 microdeletion syndrome.
PMID 19447831·J Med Genet·2009
8-other
Design of new drug molecules to be used in reversing multidrug resistance in cancer cells.
PMID 19442050·Curr Cancer Drug Targets·2009
6-review
Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
PMID 19426680·Biochem Pharmacol·2009
8-other
Fine-scale foraging behaviour of a medium-ranging marine predator.
PMID 19426254·J Anim Ecol·2009
7-preclinical
XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on september 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference Center.
PMID 19417150·Mol Cancer Ther·2009
8-other
Bortezomib induces schedule-dependent modulation of gemcitabine pharmacokinetics and pharmacodynamics in non-small cell lung cancer and blood mononuclear cells.
PMID 19383850·Mol Cancer Ther·2009
3-trial
Clinical consensus conference: survey on Gram-positive bloodstream infections with a focus on Staphylococcus aureus.
PMID 19374582·Clin Infect Dis·2009
8-other
Mechanistic study of the sPLA2-mediated hydrolysis of a thio-ester pro anticancer ether lipid.
PMID 19663381·J Am Chem Soc·2009
8-other
Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus.
PMID 19636380·PLoS One·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- UNIT 6180 BOX 245
APO, AE 09604 - Phone
- (043) 430-5056
Quick Facts
- NPI
- 1538141320
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile